PRELUDE CAPITAL MANAGEMENT, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$96,000
+37.1%
11,600
+12.6%
0.00%0.0%
Q4 2020$70,000
-84.2%
10,300
-74.1%
0.00%
-90.5%
Q3 2020$443,000
+41.1%
39,800
-20.6%
0.02%
+23.5%
Q2 2020$314,000
+554.2%
50,100
+92.7%
0.02%
+466.7%
Q1 2020$48,000
-4.0%
26,000
+168.2%
0.00%
-25.0%
Q1 2018$50,000
+35.1%
9,6950.0%0.00%
+33.3%
Q4 2017$37,0009,6950.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders